Comparing adult and pediatric Hodgkin lymphoma in the Surveillance, Epidemiology and End Results Program, 19882005

An analysis of 21 734 cases

Faiha Bazzeh, Rawad Rihani, Scott Howard, Iyad Sultan

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

We analyzed data from 18 898 adults (age ≥20 years) and 2836 children/adolescents reported in the Surveillance, Epidemiology and End Results (SEER) database as having Hodgkin lymphoma (HL), diagnosed from 1988 to 2005. The nodular sclerosis subtype was significantly more common in the pediatric age group (76% in children/adolescents vs. 61% in adults, p<0.001). The mixed cellularity subtype was more prevalent in children <10 years old (22%), but less likely in older children/adolescents (8.5%). Systemic symptoms were reported in 39% of children/adolescents and in 48% of adults (p<0.001). Children/adolescents had significantly better HL-specific survival than adults (5-year survival rate, 96% ± 0.4% vs.88% ± 0.3%, p<0.001). Using a Cox proportional-hazards regression model in patients with classical HL, the prognostic factors significantly impacting survival were age, histology, stage, B symptoms, year of diagnosis, and race. The only adverse prognostic factors that were significant when this analysis was restricted to children/adolescents were stage IV disease and the presence of B symptoms. In conclusion, several differences in clinicopathologic features and outcomes were identified between children/adolescents and adults with HL, and this was particularly noted in young children (<10 years).

Original languageEnglish (US)
Pages (from-to)2198-2207
Number of pages10
JournalLeukemia and Lymphoma
Volume51
Issue number12
DOIs
StatePublished - Dec 1 2010

Fingerprint

SEER Program
Hodgkin Disease
Pediatrics
Survival
Sclerosis
Proportional Hazards Models
Histology
Epidemiology
Survival Rate
Age Groups
Databases

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Comparing adult and pediatric Hodgkin lymphoma in the Surveillance, Epidemiology and End Results Program, 19882005 : An analysis of 21 734 cases. / Bazzeh, Faiha; Rihani, Rawad; Howard, Scott; Sultan, Iyad.

In: Leukemia and Lymphoma, Vol. 51, No. 12, 01.12.2010, p. 2198-2207.

Research output: Contribution to journalArticle

@article{ce7dab2acf52498291c0a688f14d21d5,
title = "Comparing adult and pediatric Hodgkin lymphoma in the Surveillance, Epidemiology and End Results Program, 19882005: An analysis of 21 734 cases",
abstract = "We analyzed data from 18 898 adults (age ≥20 years) and 2836 children/adolescents reported in the Surveillance, Epidemiology and End Results (SEER) database as having Hodgkin lymphoma (HL), diagnosed from 1988 to 2005. The nodular sclerosis subtype was significantly more common in the pediatric age group (76{\%} in children/adolescents vs. 61{\%} in adults, p<0.001). The mixed cellularity subtype was more prevalent in children <10 years old (22{\%}), but less likely in older children/adolescents (8.5{\%}). Systemic symptoms were reported in 39{\%} of children/adolescents and in 48{\%} of adults (p<0.001). Children/adolescents had significantly better HL-specific survival than adults (5-year survival rate, 96{\%} ± 0.4{\%} vs.88{\%} ± 0.3{\%}, p<0.001). Using a Cox proportional-hazards regression model in patients with classical HL, the prognostic factors significantly impacting survival were age, histology, stage, B symptoms, year of diagnosis, and race. The only adverse prognostic factors that were significant when this analysis was restricted to children/adolescents were stage IV disease and the presence of B symptoms. In conclusion, several differences in clinicopathologic features and outcomes were identified between children/adolescents and adults with HL, and this was particularly noted in young children (<10 years).",
author = "Faiha Bazzeh and Rawad Rihani and Scott Howard and Iyad Sultan",
year = "2010",
month = "12",
day = "1",
doi = "10.3109/10428194.2010.525724",
language = "English (US)",
volume = "51",
pages = "2198--2207",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "12",

}

TY - JOUR

T1 - Comparing adult and pediatric Hodgkin lymphoma in the Surveillance, Epidemiology and End Results Program, 19882005

T2 - An analysis of 21 734 cases

AU - Bazzeh, Faiha

AU - Rihani, Rawad

AU - Howard, Scott

AU - Sultan, Iyad

PY - 2010/12/1

Y1 - 2010/12/1

N2 - We analyzed data from 18 898 adults (age ≥20 years) and 2836 children/adolescents reported in the Surveillance, Epidemiology and End Results (SEER) database as having Hodgkin lymphoma (HL), diagnosed from 1988 to 2005. The nodular sclerosis subtype was significantly more common in the pediatric age group (76% in children/adolescents vs. 61% in adults, p<0.001). The mixed cellularity subtype was more prevalent in children <10 years old (22%), but less likely in older children/adolescents (8.5%). Systemic symptoms were reported in 39% of children/adolescents and in 48% of adults (p<0.001). Children/adolescents had significantly better HL-specific survival than adults (5-year survival rate, 96% ± 0.4% vs.88% ± 0.3%, p<0.001). Using a Cox proportional-hazards regression model in patients with classical HL, the prognostic factors significantly impacting survival were age, histology, stage, B symptoms, year of diagnosis, and race. The only adverse prognostic factors that were significant when this analysis was restricted to children/adolescents were stage IV disease and the presence of B symptoms. In conclusion, several differences in clinicopathologic features and outcomes were identified between children/adolescents and adults with HL, and this was particularly noted in young children (<10 years).

AB - We analyzed data from 18 898 adults (age ≥20 years) and 2836 children/adolescents reported in the Surveillance, Epidemiology and End Results (SEER) database as having Hodgkin lymphoma (HL), diagnosed from 1988 to 2005. The nodular sclerosis subtype was significantly more common in the pediatric age group (76% in children/adolescents vs. 61% in adults, p<0.001). The mixed cellularity subtype was more prevalent in children <10 years old (22%), but less likely in older children/adolescents (8.5%). Systemic symptoms were reported in 39% of children/adolescents and in 48% of adults (p<0.001). Children/adolescents had significantly better HL-specific survival than adults (5-year survival rate, 96% ± 0.4% vs.88% ± 0.3%, p<0.001). Using a Cox proportional-hazards regression model in patients with classical HL, the prognostic factors significantly impacting survival were age, histology, stage, B symptoms, year of diagnosis, and race. The only adverse prognostic factors that were significant when this analysis was restricted to children/adolescents were stage IV disease and the presence of B symptoms. In conclusion, several differences in clinicopathologic features and outcomes were identified between children/adolescents and adults with HL, and this was particularly noted in young children (<10 years).

UR - http://www.scopus.com/inward/record.url?scp=78650156404&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650156404&partnerID=8YFLogxK

U2 - 10.3109/10428194.2010.525724

DO - 10.3109/10428194.2010.525724

M3 - Article

VL - 51

SP - 2198

EP - 2207

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 12

ER -